[1] Stratton IM, Adler AI, Neil HA, et al.Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study[J]. BMJ,2000,321(7258):405-412. [2] Ceriello A.Postprandial hyperglycemia and diabetes complications: is it time to treat?[J]. Diabetes,2005,54(1):1-7. [3] O'Sullivan EP, Dinneen SF. Benefits of early intensive glucose control to prevent diabetes complications were sustained for up to 10 years[J]. Evid Based Med,2009, 14(1):9-10. [4] Monnier L, Mas E, Ginet C, et al.Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes[J]. JAMA,2006,295(14):1681-1687. [5] Brownlee M, Hirsch IB.Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications[J]. JAMA,2006,295(14):1707-1708. [6] Bergenstal RM.Glycemic Variability and Diabetes Complications: Does It Matter? Simply Put, There Are Better Glycemic Markers![J]. Diabetes Care,2015,38(8):1615-1621. [7] del Prato S, Marchetti P, Bonadonna RC. Phasic insulin release and metabolic regulation in type 2 diabetes[J]. Diabetes,2002,51(Suppl 1):S109-S116. [8] Service FJ, Nelson RL.Characteristics of glycemic stabi-lity[J]. Diabetes Care,1980,3(1):58-62. [9] Kohnert KD, Augstein P, Zander E, et al.Glycemic varia-bility correlates strongly with postprandial beta-cell dysfunction in a segment of type 2 diabetic patients using oral hypoglycemic agents[J]. Diabetes Care,2009,32(6):1058-1062. [10] Jin SM, Kim TH, Bae JC, et al.Clinical factors associa-ted with absolute and relative measures of glycemic va-riability determined by continuous glucose monitoring: an analysis of 480 subjects[J]. Diabetes Res Clin Pract,2014,104(2):266-272. [11] 周健, 贾伟平. 血糖稳定性的意义及临床评估[J]. 中华医学杂志,2006,92(30):2154-2157. [12] 刘晓峰, 刘纯. 当前几种动态血糖监测系统的比较[J]. 国际内分泌代谢杂志,2009,29(3):197-200. [13] Service FJ.Glucose variability[J]. Diabetes,2013,62(5):1398-1404. [14] de Vries JH. Glucose variability: where it is important and how to measure it[J]. Diabetes,2013,62(5):1405-1408. [15] Service FJ, Molnar GD, Rosevear JW, et al.Mean amplitude of glycemic excursions, a measure of diabetic instability[J]. Diabetes,1970,19(9):644-655. [16] Greven WL, Beulens JW, Biesma DH, et al.Glycemic variability in inadequately controlled type 1 diabetes and type 2 diabetes on intensive insulin therapy: a cross-sectional, observational study[J]. Diabetes Technol Ther,2010,12(9):695-699. [17] Murata GH, Duckworth WC, Shah JH, et al.Sources of glucose variability in insulin-treated type 2 diabetes: the Diabetes Outcomes in Veterans Study(DOVES)[J]. Clin Endocrinol (Oxf),2004,60(4):451-456. [18] Gjesing AP, Pedersen O.'Omics'-driven discoveries in prevention and treatment of type 2 diabetes[J]. Eur J Clin Invest,2012,42(6):579-588. [19] Xu M, Huang Y, Xie L, et al.Diabetes and Risk of Arterial Stiffness: A Mendelian Randomization Analysis[J]. Diabetes,2016,65(6):1731-1740. [20] Chen J, Wildman RP, Hamm LL, et al.Association between inflammation and insulin resistance in U.S. nondia-betic adults: results from the Third National Health and Nutrition Examination Survey[J]. Diabetes Care,2004,27(12):2960-2965. [21] Avula NR, Shenoy D. Evaluation of Association of Hyperuricaemia with Metabolic Syndrome and Insulin Resistance[J]. J Clin Diagn Res,2016,10(12):OC32-OC34. [22] 王天怡, 敖虎山. 非体外循环冠状动脉旁路移植术术中血糖波动与术后高血糖的关系[J]. 安徽医学,2017, 38(7):877-880. [23] Zhang Y, Lee ET, Howard BV, et al.Insulin resistance, incident cardiovascular diseases, and decreased kidney function among nondiabetic American Indians: the Strong Heart Study[J]. Diabetes Care,2013,36(10):3195-3200. |